Advertisement

Translational Stroke Research

, Volume 9, Issue 4, pp 340–346 | Cite as

Heroin Use Is Associated with Ruptured Saccular Aneurysms

  • Anil Can
  • Victor M. Castro
  • Yildirim H. Ozdemir
  • Sarajune Dagen
  • Dmitriy Dligach
  • Sean Finan
  • Sheng Yu
  • Vivian Gainer
  • Nancy A. Shadick
  • Guergana Savova
  • Shawn Murphy
  • Tianxi Cai
  • Scott T. Weiss
  • Rose Du
Original Article

Abstract

While cocaine use is thought to be associated with aneurysmal rupture, it is not known whether heroin use increases the risk of rupture in patients with non-mycotic saccular aneurysms. Our goal was to investigate the association between heroin and cocaine use and the rupture of saccular non-mycotic aneurysms. The medical records of 4701 patients with 6411 intracranial aneurysms, including 1201 prospective patients, diagnosed at the Brigham and Women’s Hospital and Massachusetts General Hospital between 1990 and 2016 were reviewed and analyzed. Patients were separated into ruptured and non-ruptured groups. Univariable and multivariable logistic regression analyses were performed to determine the association between heroin, cocaine, and methadone use and the presence of ruptured intracranial aneurysms. In multivariable analysis, current heroin use was significantly associated with rupture status (OR 3.23, 95% CI 1.33–7.83) whereas former heroin use (with and without methadone replacement therapy), and current and former cocaine use were not significantly associated with intracranial aneurysm rupture. In the present study, heroin rather than cocaine use is significantly associated with intracranial aneurysm rupture in patients with non-mycotic saccular cerebral aneurysms, emphasizing the possible role of heroin in the pathophysiology of aneurysm rupture and the importance of heroin cessation in patients harboring unruptured intracranial aneurysms.

Keywords

Heroin Cocaine Opioids Aneurysm Subarachnoid hemorrhage 

Notes

Funding

This study was funded by Partners Personalized Medicine (R.D.).

Compliance with Ethical Standards

Conflict of Interest

All authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was waived by the institutional review board.

Supplementary material

12975_2017_582_MOESM1_ESM.docx (101 kb)
Supplemental Table 1 (DOCX 101 kb)
12975_2017_582_MOESM2_ESM.docx (87 kb)
ESM 1 (DOCX 87 kb)

References

  1. 1.
    Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users—United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015;64(26):719–25.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Hop JW, Rinkel GJ, Algra A, van Gijn J. Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2001;95(6):957–63.  https://doi.org/10.3171/jns.2001.95.6.0957.CrossRefPubMedGoogle Scholar
  3. 3.
    Buttner A, Mall G, Penning R, Weis S. The neuropathology of heroin abuse. Forensic Sci Int. 2000;113(1–3):435–42.CrossRefPubMedGoogle Scholar
  4. 4.
    Cadet JL, Bisagno V, Milroy CM. Neuropathology of substance use disorders. Acta Neuropathol. 2014;127(1):91–107.  https://doi.org/10.1007/s00401-013-1221-7.CrossRefPubMedGoogle Scholar
  5. 5.
    Amine AR. Neurosurgical complications of heroin addiction: brain abscess and mycotic aneurysm. Surg Neurol. 1977;7(6):385–6.PubMedGoogle Scholar
  6. 6.
    Gilroy J, Andaya L, Thomas VJ. Intracranial mycotic aneurysms and subacute bacterial endocarditis in heroin addiction. Neurology. 1973;23(11):1193–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Leipzig TJ, Brown FD. Treatment of mycotic aneurysms. Surg Neurol. 1985;23(4):403–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Brust JC. Neurological complications of substance abuse. Res Publ Assoc Res Nerv Ment Dis. 1992;70:193–203.PubMedGoogle Scholar
  9. 9.
    SAMHSA. Results from the 2013 National Survey on drug use and health: summary of national findings. NSDUH series H-48, HHS publication no (SMA) 13-4863. Rockville, MA2014.Google Scholar
  10. 10.
    Akalin A, Kormaksson M, Li S, Garrett-Bakelman FE, Figueroa ME, Melnick A, et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 2012;13(10):R87.  https://doi.org/10.1186/gb-2012-13-10-r87.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Oyesiku NM, Colohan AR, Barrow DL, Reisner A. Cocaine-induced aneurysmal rupture: an emergent negative factor in the natural history of intracranial aneurysms? Neurosurgery. 1993;32(4):518–25. discussion 25-6CrossRefPubMedGoogle Scholar
  12. 12.
    Vannemreddy P, Caldito G, Willis B, Nanda A. Influence of cocaine on ruptured intracranial aneurysms: a case control study of poor prognostic indicators. J Neurosurg. 2008;108(3):470–6.  https://doi.org/10.3171/JNS/2008/108/3/0470.CrossRefPubMedGoogle Scholar
  13. 13.
    Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch Neurol. 1989;46(9):989–93.CrossRefPubMedGoogle Scholar
  14. 14.
    Levine SR, Brust JC, Futrell N, Ho KL, Blake D, Millikan CH, et al. Cerebrovascular complications of the use of the “crack” form of alkaloidal cocaine. N Engl J Med. 1990;323(11):699–704.  https://doi.org/10.1056/NEJM199009133231102.CrossRefPubMedGoogle Scholar
  15. 15.
    Castro VM, Dligach D, Finan S, Yu S, Can A, Abd-El-Barr M, et al. Large-scale identification of patients with cerebral aneurysms using natural language processing. Neurology. 2017;88(2):164–8.  https://doi.org/10.1212/WNL.0000000000003490.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Brust JC, Richter RW. Stroke associated with addiction to heroin. J Neurol Neurosurg Psychiatry. 1976;39(2):194–9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Adelman LS, Aronson SM. The neuropathologic complications of narcotics addiction. Bull N Y Acad Med. 1969;45(2):225–34.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Enevoldson TP. Recreational drugs and their neurological consequences. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3):iii9–15.  https://doi.org/10.1136/jnnp.2004.045732.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Lim CS, Kiriakidis S, Sandison A, Paleolog EM, Davies AH. Hypoxia-inducible factor pathway and diseases of the vascular wall. J Vasc Surg. 2013;58(1):219–30.  https://doi.org/10.1016/j.jvs.2013.02.240.CrossRefPubMedGoogle Scholar
  20. 20.
    Tsai SH, Huang PH, Hsu YJ, Peng YJ, Lee CH, Wang JC, et al. Inhibition of hypoxia inducible factor-1alpha attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612.  https://doi.org/10.1038/srep28612.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Hagan IG, Burney K. Radiology of recreational drug abuse. Radiographics. 2007;27(4):919–40.  https://doi.org/10.1148/rg.274065103.CrossRefPubMedGoogle Scholar
  22. 22.
    Lucas CE. The impact of street drugs on trauma care. J Trauma. 2005;59(3 Suppl):S57–60. discussion S7–75CrossRefPubMedGoogle Scholar
  23. 23.
    Paranthaman SK, Khan F. Acute cardiomyopathy with recurrent pulmonary edema and hypotension following heroin overdosage. Chest. 1976;69(1):117–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Andersen SN, Skullerud K. Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int. 1999;102(1):51–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Adle-Biassette H, Marc B, Benhaiem-Sigaux N, Durigon M, Gray F. Cerebral infarctions in a drug addict inhaling heroin. Arch Anat Cytol Pathol. 1996;44(1):12–7.PubMedGoogle Scholar
  26. 26.
    Silvestrelli G, Corea F, Micheli S, Lanari A. Clinical pharmacology and vascular risk. Open Neurol J. 2010;4:64–72.  https://doi.org/10.2174/1874205X01004020064.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Haghpanah T, Afarinesh M, Divsalar KA. Review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period. Addict Health. 2010;2(1–2):9–16.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Zvetkova E, Antonova N, Ivanov I, Savov Y, Gluhcheva Y. Platelet morphological, functional and rheological properties attributable to addictions. Clin Hemorheol Microcirc. 2010;45(2–4):245–51.  https://doi.org/10.3233/CH-2010-1305. PubMedGoogle Scholar
  29. 29.
    Savov Y, Antonova N, Zvetkova E, Gluhcheva Y, Ivanov I, Sainova I. Whole blood viscosity and erythrocyte hematometric indices in chronic heroin addicts. Clin Hemorheol Microcirc. 2006;35(1–2):129–33.PubMedGoogle Scholar
  30. 30.
    Kurki MI, Hakkinen SK, Frosen J, Tulamo R, von und zu Fraunberg M, Wong G, et al. Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: an emerging regulative role of toll-like receptor signaling and nuclear factor-kappaB, hypoxia-inducible factor-1A, and ETS transcription factors. Neurosurgery. 2011;68(6):1667–1675; discussion 75-6.  https://doi.org/10.1227/NEU.0b013e318210f001.CrossRefPubMedGoogle Scholar
  31. 31.
    Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34(6):1375–81.  https://doi.org/10.1161/01.STR.0000074572.91827.F4.CrossRefPubMedGoogle Scholar
  32. 32.
    Chang TR, Kowalski RG, Caserta F, Carhuapoma JR, Tamargo RJ, Naval NS. Impact of acute cocaine use on aneurysmal subarachnoid hemorrhage. Stroke. 2013;44(7):1825–9.  https://doi.org/10.1161/STROKEAHA.111.000749.CrossRefPubMedGoogle Scholar
  33. 33.
    Conway JE, Tamargo RJ. Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2001;32(10):2338–43.CrossRefPubMedGoogle Scholar
  34. 34.
    Nanda A, Vannemreddy PS, Polin RS, Willis BK. Intracranial aneurysms and cocaine abuse: analysis of prognostic indicators. Neurosurgery. 2000;46(5):1063–7. discussion 7-9CrossRefPubMedGoogle Scholar
  35. 35.
    Qureshi AI, Suri MF, Yahia AM, Suarez JI, Guterman LR, Hopkins LN, et al. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001;49(3):607–12. discussion 12-3PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Anil Can
    • 1
  • Victor M. Castro
    • 2
  • Yildirim H. Ozdemir
    • 1
  • Sarajune Dagen
    • 1
  • Dmitriy Dligach
    • 3
    • 4
  • Sean Finan
    • 4
  • Sheng Yu
    • 5
    • 6
  • Vivian Gainer
    • 2
  • Nancy A. Shadick
    • 7
  • Guergana Savova
    • 4
  • Shawn Murphy
    • 2
    • 8
  • Tianxi Cai
    • 9
  • Scott T. Weiss
    • 5
    • 10
  • Rose Du
    • 1
    • 10
  1. 1.Department of Neurosurgery, Brigham and Women’s HospitalBostonUSA
  2. 2.Research Information Systems and ComputingPartners HealthcareBostonUSA
  3. 3.Department of Computer ScienceLoyola UniversityChicagoUSA
  4. 4.Boston Children’s Hospital Informatics ProgramBostonUSA
  5. 5.Department of MedicineBrigham and Women’s HospitalBostonUSA
  6. 6.Center for Statistical ScienceTsinghua UniversityBeijingChina
  7. 7.Division of Rheumatology, Immunology and AllergyBrigham and Women’s HospitalBostonUSA
  8. 8.Department of NeurologyMassachusetts General HospitalBostonUSA
  9. 9.BiostatisticsHarvard T. H. Chan School of Public HealthBostonUSA
  10. 10.Channing Division of Network MedicineBrigham and Women’s HospitalBostonUSA

Personalised recommendations